Articles
Thoughts on the questions that move deep tech and biopharma.
Latest
Advisory · 8 November 2026
How to make a big decision: my three-step method, now as a free handbook
Your Next Move explained step by step: preparation in writing, a 60-minute session and a written de-brief, with the research behind each part. Free download, no email form.
Read the articleLeadership · 7 November 2026
Make it so: Sir Patrick Stewart and the calm way to lead
A tribute to the actor who played Captain Picard, and what his calm way of leading means for the boardroom, for medicine and for social media.
Read the articleBiopharma deals · 4 November 2026
$358 million for the right to wait. What Boehringer’s China deal means for Europe’s biotech companies
Why a buyer pays $60 million a programme for science that has never met a patient, and what that means for Europe’s ADC and T-cell engager companies.
Read the articleAI and drug development · 2 November 2026
Sixty billion dollars, zero approved drugs. Where does AI pay off in pharma?
Why the clinic, not the molecule, decides what AI is worth in drug development.
Read the article